Suppr超能文献

不同国家补充和替代医学的法律法规。

Legal regulations of complementary and alternative medicines in different countries.

作者信息

Saraf Shailendra

机构信息

University Institute of Pharmacy, Pt. Ravi Shankar Shukla University, Raipur, Chhattisgarh, India.

出版信息

Pharmacogn Rev. 2012 Jul;6(12):154-60. doi: 10.4103/0973-7847.99950.

Abstract

Traditional medicines that formed the basis of health care throughout the world since the earliest days of mankind are still widely used and have considerable importance in international trade. Recognition of their clinical, pharmaceutical, and economic value is still growing, although this varies widely between countries and therefore regulation of exploitation and exportation is essential, together with international cooperation and coordination for their conservation so as to ensure their availability for the future. World Health Organization and European Union issued the guidelines defined the basic criteria for the evaluation of quality, safety, and efficacy of herbal medicines with the goal of assisting national regulatory authorities, scientific organizations, and manufacturers in assessing documentation, submissions, and dossiers in respect of such products. Legislative controls in respect of medicinal plants have not evolved around a structured control model. There are different ways in which countries define medicinal plants or herbs or products derived from them. The present review highlights the status of different countries adopted various approaches to licensing, dispensing, manufacturing, and trading to ensure their safety, quality, and efficacy.

摘要

自人类早期以来,构成全球医疗保健基础的传统药物仍被广泛使用,并且在国际贸易中具有相当重要的地位。尽管各国对其临床、药学和经济价值的认可程度差异很大,但对其认可仍在不断增加。因此,对传统药物的开发和出口进行监管至关重要,同时还需要开展国际合作与协调以保护这些药物,确保其未来的可得性。世界卫生组织和欧盟发布了相关指南,确定了评估草药质量、安全性和有效性的基本标准,目的是协助各国监管当局、科学组织和制造商评估此类产品的文件、申报材料和档案。关于药用植物的立法控制并非围绕结构化控制模式发展而来。各国界定药用植物或草药或其衍生产品的方式各不相同。本综述着重介绍了不同国家采取的各种许可、配药、制造和贸易方式的现状,以确保这些传统药物的安全性、质量和有效性。

相似文献

5
6
Herbal medicines in European regulation.欧洲法规中的草药
Pharmacol Res. 1997 May;35(5):355-62. doi: 10.1006/phrs.1997.0132.
7
Herbal Products Regulations in a Few Countries-A Brief Overview.一些国家的草药产品法规——简要概述
Curr Drug Discov Technol. 2019;16(4):368-371. doi: 10.2174/1570163815666181105091254.
9
Challenges and guidelines for clinical trial of herbal drugs.草药临床试验的挑战与指南
J Pharm Bioallied Sci. 2015 Oct-Dec;7(4):329-33. doi: 10.4103/0975-7406.168035.

引用本文的文献

10
Health risks from consumption of medicinal plant dietary supplements.食用药用植物膳食补充剂带来的健康风险。
Food Sci Nutr. 2020 May 19;8(7):3535-3544. doi: 10.1002/fsn3.1636. eCollection 2020 Jul.

本文引用的文献

2
Regulation and quality control of herbal drugs in Korea.韩国草药的监管与质量控制。
Toxicology. 2002 Dec 27;181-182:581-6. doi: 10.1016/s0300-483x(02)00487-0.
3
The regulation of herbal medicines in Australia.澳大利亚的草药监管。
Toxicology. 2002 Dec 27;181-182:565-70. doi: 10.1016/s0300-483x(02)00483-3.
6
Regulation of herbal medicines in Japan.日本的草药监管。
Pharmacol Res. 2000 May;41(5):515-9. doi: 10.1006/phrs.1999.0645.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验